These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW; Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762 [TBL] [Abstract][Full Text] [Related]
24. [Non-penetrating deep sclerectomy in the treatment of advanced cases of open angle glaucoma]. Gierek-Lapińska A; Leszczyński R; Wróbel A Klin Oczna; 2004; 106(1-2 Suppl):168-9. PubMed ID: 15510486 [TBL] [Abstract][Full Text] [Related]
25. [Comparative evaluation of the tolerability of proxofelin and clofelin and their effects on the eye in patients with glaucoma]. Ermakova VN; Malinina SL; Abdulkadyrova MZh Vestn Oftalmol; 2001; 117(1):6-8. PubMed ID: 11339049 [TBL] [Abstract][Full Text] [Related]
26. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma. Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932 [TBL] [Abstract][Full Text] [Related]
27. [Investigation of the biomechanical properties of the cornea in patients with normotensive and primary open-angle glaucoma]. Avetisov SE; Bubnova IA; Antonov AA Vestn Oftalmol; 2008; 124(5):14-6. PubMed ID: 19062550 [TBL] [Abstract][Full Text] [Related]
28. Treatment and vision-related quality of life in the early manifest glaucoma trial. Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC; Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074 [TBL] [Abstract][Full Text] [Related]
29. [Effects of trans-scleral laser cyclo-coagulation on intraocular pressure and visual function in patients with far advanced open-angle glaucoma]. Nesterov AP; Egorov EA; Egorov AE; Kats DV Vestn Oftalmol; 2001; 117(1):3-4. PubMed ID: 11339036 [TBL] [Abstract][Full Text] [Related]
30. Influence of diurnal variation on the intraocular pressure measurement of treated primary open-angle glaucoma during office hours. Rota-Bartelink AM; Pitt A; Story I J Glaucoma; 1996 Dec; 5(6):410-5. PubMed ID: 8946298 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Quigley HA; Friedman DS; Hahn SR Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498 [TBL] [Abstract][Full Text] [Related]
32. [Pikamilon pharmacokinetics in animals]. Dorofeev BF; Kholodov LE Farmakol Toksikol; 1991; 54(2):66-9. PubMed ID: 1884802 [TBL] [Abstract][Full Text] [Related]
37. [Correction of microcirculatory disorders in patients with open angle glaucoma with rheopolyglycine]. Sobko EG Oftalmol Zh; 1985; (6):338-40. PubMed ID: 4069534 [No Abstract] [Full Text] [Related]
38. Open letter to clinicians and pharmacists from Berkeley Phillips, UK medical director, and Seema Patel, established pharma medical director, Pfizer UK. Phillips B; Patel S BMJ; 2015 Jul; 350():h3645. PubMed ID: 26152319 [No Abstract] [Full Text] [Related]